Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03034603Not ApplicableCompleted

The Safety and Efficacy Test of Nutri-PEITC Jelly in Head and Neck Cancer Patients

Role: lead

NCT03035825Not ApplicableCompleted

Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients

Role: lead

NCT03700983Not ApplicableCompleted

A Pharmacokinetic Study of Nutri-PEITC Jelly in Head and Neck Cancer Survivors

Role: lead

NCT02317172Not ApplicableCompleted

Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases

Role: lead

NCT01885065Not ApplicableCompleted

Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients

Role: lead

NCT01871155Not ApplicableCompleted

Effect of Nutri-jelly on Quality of Life in Head and Neck Cancer Patients

Role: lead

All 6 trials loaded